We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HUMDF market cap is 214.07M. The company's latest EPS is CNY -0.1928 and P/E is -1.04.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 0 | 0 | 0 | 0 | 17.6M |
| Operating Income | -399.25M | -447.96M | -351.28M | -316.45M | -230.11M |
| Net Income | -3.6B | -425.27M | -393.13M | -325.73M | -203.51M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.49B | 1.25B | 1.2B | 903.55M | 1.12B |
| Total Liabilities | 86.76M | 193.99M | 466.03M | 453.22M | 841.92M |
| Total Equity | 1.4B | 1.06B | 732.5M | 450.33M | 279.58M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -269.42M | -342.07M | -20.91M | -272.98M | -230.11M |
| Investing | 12.49M | -9.52M | -14.09M | -68.22M | -4.75M |
| Financing | 1.46B | -1.24M | -7.26M | -6.13M | 21.48M |
| Market Cap | 214.07M |
| Price to Earnings Ratio | -1.04 |
| Price to Sales Ratio | 11.98 |
| Price to Cash Ratio | 0.43 |
| Price to Book Ratio | 0.76 |
| Dividend Yield | - |
| Shares Outstanding | 1.06B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.2028 |
| 52 Week Low | 0.2028 |
| Spread (Intraday) | 50k (100%) |
| Company Name | Hua Medicine (PK) |
| Address |
po box 309 grand cayman KY1-1104 |
| Website | https://www.huamedicine.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
